Health for Sale | Big Pharma Exposed скачать в хорошем качестве

Health for Sale | Big Pharma Exposed

Health for Sale - Exposes how a handful of pharmaceutical giants dominate global health, from drug pricing to research priorities. By following the flow of patents, profits, and policies, the film uncovers a system where business often prevails over human life. A powerful investigation into the true cost of medicine. Director: Michele Mellara Alessandro Rossi Genre: Investigative Documentary, Economy, Public Health Country: France / Italy / International Language: English Also Known As: Big Pharma: Who Owns Our Health? Release Date: Mid-2000s (ARTE / RAI International co-production) Duration: approx. 52 minutes Production: ARTE France / RAI / Médecins Sans Frontières (participation) Filming Locations: Geneva, India, South Africa, Brazil, Europe, USA Synopsis: Access to essential pharmaceutical drugs in developing countries is critical. Why is it that 15 million people die from easily curable diseases in the Southern hemisphere every year? The film links together the First and Third World in a long trip inside the Pharma maze. The film investigates the problem of access to essential pharmaceutical drugs in developing countries, taking into account economic, political, medical and social perspectives. Why is it that fifteen million people die from easily curable diseases in the Southern hemisphere every year? That’s forty thousand people a day, a stadium on cup final day. A daily massacre that could so easily be avoided. Why isn’t it? In an attempt to answer this question, the documentary links together the First and Third World in a long trip inside the Pharma maze. The worldwide pharmaceutical market is dominated by the so-called Big-Pharma, which is composed by no more than 10 pharmaceutical companies based in USA or Europe. Thanks to the TRIPS Agreements, created by the WTO (World Trade Organization) in 1995, medicines is treated like any other goods. This means that the pharmaceutical companies owning the large number of patents on drugs worldwide can act as monopolists deciding and imposing the prizes. Further more they can decide the type of research to be made, without taking into consideration the needs of developing countries. Chapters: 00:00 – The Power and Profit of Big Pharma Big Pharma’s global dominance is introduced: profits greater than the entire Fortune 500 combined, the world’s best-selling drugs, and how the pharmaceutical market is concentrated in rich countries. The film sets the stage for the economic and ethical crisis around access to medicine. 08:10 – Patents, TRIPS and the Global Price Barrier From Geneva, the documentary unpacks the TRIPS agreement: how international patent rules created 20-year monopolies, blocked generics, and made essential medicines unaffordable for most of the Global South. Experts explain how TRIPS shifted intellectual-property power to multinationals. 16:25 – Flexibilities, Loopholes and the Battle for Generic Medicines Compulsory licenses, parallel imports and the political pressure against developing nations trying to use these legal tools. The South Africa AIDS lawsuit becomes a turning point: 39 pharma companies sue the government for trying to buy generics—but ultimately lose. 24:55 – India: The World’s Pharmacy Under Threat India’s generic industry—Ranbaxy, Cipla—supplies 80% of the affordable medicines for the Global South. But TRIPS forces India to reintroduce product patents, triggering court battles like Novartis vs. the Indian government. Stakes: cancer drugs, HIV treatments, and millions of lives. 32:40 – Neglected Diseases: When Profit Does Not Bring Innovation Malaria, tuberculosis, and AIDS in Africa: drug resistance grows while R&D collapses. Pharma invests heavily in marketing but little in new molecules. New “evergreening” patent strategies extend monopolies without innovation. MSF and public-health experts warn of deep structural failure. 41:10 – The Future of Access: Public Health vs. Corporate Power Vaccines, drug trials in developing countries, Big Pharma lobbying, rising drug prices in rich nations, and the privatization of medical research. The film ends questioning how long global health systems can sustain the cost of medicines—and who will control future innovation. Also Known As (AKA): SUPPORT US! ✘ Membership - https://bit.ly/3q5XPBh MORE DOCS! ► Gold: https://bit.ly/2IRZ0OA ► World Economy: https://bit.ly/36QlhEM ► All Playlists: https://bit.ly/3lOiCll #BigPharma #Documentary #PublicHealth COPYRIGHT: All of the films published by us are legally licensed. We have acquired the rights (at least for specific territories) from the rightholders by contract. If you have questions please send an email to: info[at]moconomy.tv, Moconomy GmbH, www.moconomy.tv.